Abstract:The purpose of this study was to investigate the clinical value of plasma thrombomodulin (PTM) in different diseases or in different severity or complications of diseases, PTM in 979 patients and 60 healthy controls was determined by ELISA method. The results showed that the PTM level in the control group was 20.40 ± 7.72 μg/L, there was no difference in sex and ages. In chronic primary glomerular disease, the PTM level in chronic renal failure (CRF)group was higher than that in non-CRF group (P ＜ 0.01 ). PTM level ＞ 70 μg/L was defined as its positive criterion.The sensitivity, specificity and positive predictive value in PTM were 85.7%, 82.4% and 77.8% respectively. The PTM level in septemia group was higher than that in non-septemia group ( P ＜ 0.01 ), the sensitivity, specificity and positive predictive value were 86.6%, 89.5% and 76.5% respectively ( ＞ 50 μg/L as its positive criterion). With respect of multiple trauma, the PTM level in multiple organ failare (MOF) group was higher than that in non-MOF group ( P ＜0.01 ), while the sensitivity, specificity and positive predictive value were 77.8%, 77.3% and 73.7% respectively ( ＞40 μg/L as its positive criterion). For systemic lupus erythematosus (SLE), the PTM level in the patients with albuminuria was higher than that in the patients without albuminuria (P ＜ 0.01 ), and the sensitivity, specificity and positive predictive value were 77.8%, 92.3% and 93.3% respectively ( ＞ 35.54 μg/L as its positive criterion). For diabetes, the PTM level in complication group was higher than that in group without complications, the sensitivity, specificity and positive predictive value were 53.4% ,97.1% and 98.6% respectively ( ＞ 35.54 μg/L as its positive criterion).The PTM level in microangiopathy group was higher than that in macroangiopathy group (P ＜ 0.01 ). The sensitivity,specificity and positive predictive value were 71.2%, 97.1% and 97.9% respectively. Acute leukemia (AL) and multiple myeloma (MM) had higher PTM level and PTM level was extremely high when renal failure developed ( P ＜ 0.01 ). As compared the acute stage with the restoration stage in stroke, pre-chemotherapeutics with post-chemotherapeutics in AL and MM, and pre-operation with post-operation in cancer, the PTM level was connected with clinical development. The PTM level in the patients with microangiopathy was higher than that in the patients with macroangiopathy (P＜ 0.01 ). The defined PTM level was higher than its normal upper limit as PTM positive criterion in microangiopathy diseases, the sensitivity, specificity and positive predictive value were 77.7%, 71.2% and 75.6% respectively. It is concluded that PTM level is a good criterion in evaluating the microangiopathy, and PTM is also a valuable indicator in prediction or assessment of the severity of diseases, or evaluation of therapeutic effectiveness.

[Detection of Thrombus Precursor Protein and Its Clinical Significance].

Analysis of correlation between oxidized low density lipoprotein and thrombus precursor protein with acute cerebral infarction

[The Dynamic Analysis and the Clinical Significance of Vascular Endothelial Cell Markers and Hemolysis Parameters in Thrombotic Thrombocytopenic Purpura].

[A Clinical Study of Congenital Thrombotic Thrombocytopenic Purpura].

Current Pathological and Laboratory Considerations in the Diagnosis of Disseminated Intravascular Coagulation

A Case of False Decrease of Plasma D-Dimer

TAT and PIC Better Than D-dimer in Monitoring Hypercoagulability of Cancer Patients

[Effect of Thrombelastography in the Diagnosis of Disseminated Intravascular Coagulation in Children].

Analysis of the diagnostic value of coagulation markers and coagulation function indices on the occurrence of DIC in sepsis and its prognosis

The Combination of the Lactate Dehydrogenase/Hemoglobin Ratio with the PLASMIC Score Facilitates Differentiation of TTP from Septic DIC Without Identification of Schistocytes

Systematic review of diagnostic efficiency of laboratory tests used for disseminated intravascular coagulation

The Significance of Plasma Thrombomodulin in Appraising Vascular Lesions and Complication in Diseases

[The Changes and Their Clinical Significance of D-dimer and Platelet Glycoprotein in Patients with Coronary Heart Disease].

Clinical Value of Combined Detection of UA and MMP-9 in Evaluating Bleeding Transformation and Prognosis After Thrombolysis in Acute Cerebral Infarction

Characteristics of emergency patients with markedly elevated D-dimer levels

Clinical Study of Plasma Thrombomodulin Detection

Clinical Significance in Determination of Plasma Thrombomodulin Protein C Antigen and D - Dimer in Liver Cancer Patients.

[The value of D-dimer for etiological diagnosis of mortal chest pain: an analysis of 438 cases].

Plasma Soluble Fibrin Is Useful for the Diagnosis of Thrombotic Diseases

Diagnostic and Prognostic Value of TAT, PIC, TM, and t-PAIC in Malignant Tumor Patients With Venous Thrombosis

A Proposal of the Modification of Japanese Society on Thrombosis and Hemostasis (JSTH) Disseminated Intravascular Coagulation (DIC) Diagnostic Criteria for Sepsis-Associated DIC